What impact will Alzheimer’s drug donanemab have?

Photo caption: Evidence of Alzheimer’s disease on PET scans. Photo credit: Brian Snyder / Reuters. Article by Ian Sample. The Guardian – July 17, 2023.

A major clinical trial of an Alzheimer’s drug has confirmed that the therapy can slow the rate at which patients deteriorate, raising hopes that medicine may one day halt the most common form of dementia. What impact could the new drug have? […]

Click here to view original web page at www.theguardian.com